Relmada Therapeutics (RLMD) Tops Q1 EPS by 26c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA

6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

May 9, 2024 5:27 PM EDT

Price: $6.28 -1.72%

EPS Growth %: +36.7%

Today's EPS Names:
CRMT, More

Relmada Therapeutics (NASDAQ: RLMD) reported Q1 EPS of ($0.72), $0.26 better than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Relmada Therapeutics (RLMD) click here.

Earnings

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!